Cyclin-dependent kinase 5
Generated by GPT-5-miniExpansion Funnel Raw 71 → Dedup 0 → NER 0 → Enqueued 0
| Cyclin-dependent kinase 5 | |
|---|---|
| Name | Cyclin-dependent kinase 5 |
| Other names | Cdk5 |
| Activity | Serine/threonine kinase |
Cyclin-dependent kinase 5 is a proline-directed serine/threonine kinase central to neuronal development and function. It is distinct from other cyclin-dependent kinases in activation mechanism and tissue distribution, and has been studied across neuroscience, cell biology, and clinical research. Prominent research groups at institutions such as Max Planck Society, Howard Hughes Medical Institute, Harvard University, Massachusetts Institute of Technology, and Stanford University have advanced understanding of its biochemistry and pathology.
Introduction
Cyclin-dependent kinase 5 emerged as a focus in molecular neuroscience through studies linked to Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and developmental disorders investigated by teams at National Institutes of Health, Wellcome Trust, and European Molecular Biology Laboratory. Early characterization involved comparisons with kinases described by researchers at Cold Spring Harbor Laboratory and biochemical analyses influenced by techniques from MRC Laboratory of Molecular Biology. The enzyme's atypical regulation compared with kinases in pathways studied at Yale University, University of Oxford, and Columbia University highlighted unique roles in neuronal migration, synaptic plasticity, and cytoskeletal dynamics.
Structure and Regulation
The catalytic core shares topology with kinases characterized in work from ETH Zurich and University of Cambridge, but activation depends on neuron-specific regulatory proteins identified in studies at Johns Hopkins University and University College London. Activators include proteins discovered in screens using methods developed at Broad Institute and Sanger Institute, with post-translational modifications examined by laboratories at Scripps Research Institute and Karolinska Institutet. Subcellular targeting and scaffolding interactions have been mapped in projects in collaboration with Duke University and Princeton University, revealing modulation by phosphorylation and binding partners implicated by structural studies from Riken and Institut Pasteur.
Biological Functions
Functionally, the kinase coordinates processes first linked to neurobiology by investigators at University of California, San Francisco and University of Pennsylvania, including neuronal migration studied in models used by groups at Baylor College of Medicine and University of Toronto. It regulates cytoskeletal elements and vesicle trafficking characterized in research from Rockefeller University and MIT, and contributes to synaptic transmission explored in laboratories at New York University and King's College London. Roles in learning and memory have been evaluated in behavioral paradigms popularized at Cold Spring Harbor Laboratory and Olsson Laboratory, with electrophysiological correlates measured using equipment from Agilent Technologies and collaborations with National Institute of Mental Health.
Role in Disease
Aberrant activity has been implicated in neurodegenerative conditions that engaged consortia such as Alzheimer's Association, Michael J. Fox Foundation, and Huntington's Disease Society of America. Pathological mechanisms overlap with pathways studied in cancer biology at Dana-Farber Cancer Institute and inflammation research at Centers for Disease Control and Prevention when non-neuronal roles are considered. Genetic and proteomic studies from Genentech and GlaxoSmithKline further linked dysregulation to cellular stress responses investigated by laboratories at Institut Curie and Université Paris-Saclay, leading to biomarker efforts in clinical centers like Mayo Clinic and Cleveland Clinic.
Pharmacology and Inhibitors
Small-molecule inhibition has been pursued by pharmaceutical teams at Pfizer, Novartis, AstraZeneca, and Johnson & Johnson using screening platforms developed at Takeda and Eli Lilly and Company. Tool compounds and peptide inhibitors were characterized with assays standardized in collaborations with American Chemical Society and structural insights provided by synchrotron facilities such as European Synchrotron Radiation Facility and Advanced Photon Source. Preclinical evaluation has taken place in laboratories affiliated with GlaxoSmithKline and academic centers like University of California, Los Angeles and University of Michigan.
Research Tools and Models
Experimental systems include transgenic mouse models generated at facilities like Jackson Laboratory and conditional alleles developed with Cre drivers popularized by groups at The Francis Crick Institute and Cold Spring Harbor Laboratory. Cellular assays employ human induced pluripotent stem cell lines established in protocols from Kyoto University and Stanford University and high-resolution imaging using platforms from Zeiss and Leica Microsystems. Omics approaches have been integrated using pipelines from Broad Institute, European Bioinformatics Institute, and National Center for Biotechnology Information.